Ligand validation:8VL8

SER: SERINE

SER is a Ligand Of Interest in 8VL8 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8VL8_SER_D_204	85%	46%	0.096	0.962	0.89	1.2	-	-	1	0	100%	1
8VL8_SER_A_202	79%	62%	0.116	0.962	0.92	0.53	-	-	0	0	100%	1
8VL8_SER_B_208	76%	45%	0.107	0.944	0.67	1.44	-	2	0	0	100%	1
8VL8_SER_C_204	71%	52%	0.102	0.922	1.2	0.69	1	-	0	0	100%	1
8VL8_SER_E_202	59%	41%	0.138	0.92	0.91	1.39	-	-	2	0	100%	1
8FYV_SER_A_203	84%	35%	0.101	0.964	0.99	1.55	1	2	0	0	100%	1
4RJY_SER_D_403	100%	59%	0.032	0.992	1.12	0.47	-	-	0	0	100%	0.5
1OAU_SER_J_500	99%	1%	0.048	0.982	0.42	7.07	-	3	0	0	100%	1
4IY7_SER_B_401	98%	33%	0.054	0.975	1.09	1.53	-	1	0	0	100%	1
6HZF_SER_A_901	96%	30%	0.057	0.968	0.86	1.91	-	2	0	0	100%	1
4YJ5_SER_B_603	96%	43%	0.073	0.984	0.87	1.31	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.